Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AvePoint (AVPT) Cash & Equivalents: 2019-2025

Historic Cash & Equivalents for AvePoint (AVPT) over the last 5 years, with Sep 2025 value amounting to $471.6 million.

  • AvePoint's Cash & Equivalents rose 88.80% to $471.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $471.6 million, marking a year-over-year increase of 88.80%. This contributed to the annual value of $290.7 million for FY2024, which is 30.28% up from last year.
  • As of Q3 2025, AvePoint's Cash & Equivalents stood at $471.6 million, which was up 9.73% from $429.8 million recorded in Q2 2025.
  • AvePoint's Cash & Equivalents' 5-year high stood at $471.6 million during Q3 2025, with a 5-year trough of $139,492 in Q1 2021.
  • For the 3-year period, AvePoint's Cash & Equivalents averaged around $283.0 million, with its median value being $228.8 million (2023).
  • Per our database at Business Quant, AvePoint's Cash & Equivalents plummeted by 81.66% in 2021 and then spiked by 56,364.89% in 2022.
  • Quarterly analysis of 5 years shows AvePoint's Cash & Equivalents stood at $268.2 million in 2021, then decreased by 15.30% to $227.2 million in 2022, then fell by 1.77% to $223.2 million in 2023, then spiked by 30.28% to $290.7 million in 2024, then surged by 88.80% to $471.6 million in 2025.
  • Its last three reported values are $471.6 million in Q3 2025, $429.8 million for Q2 2025, and $351.5 million during Q1 2025.